RxDoctor Payments Data

Gloria Cruz, MD

Family Medicine · Hamilton, NJNPI 1992760086

Payments from drug & device makers

$842in general payments, 2019–2025

Across 73 payments — averaging $11.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kowa Pharmaceuticals America, Inc.$394
  • AbbVie$125
  • Lilly USA, LLC$101
  • Novo Nordisk$67
  • Takeda Pharmaceuticals U.S.A., Inc.$33
  • GSK$30
  • plus $93 from 6 others

What the payments were for

  • Food & beverage$83099%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$842 in reported general payments places this provider in the 60th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$32,243
Medicare patients
133
Services billed
317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide44$80,160
JardianceEmpagliflozin16$25,335
TradjentaLinagliptin15$22,712
MounjaroTirzepatide14$20,512
JanuviaSitagliptin Phosphate12$15,104
VascepaIcosapent Ethyl15$9,467
SynthroidLevothyroxine Sodium53$4,214
Estradiol12$3,360
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide58$3,206
Levothyroxine Sodium167$2,214
Rosuvastatin Calcium178$2,087
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide28$1,444
Ezetimibe49$1,424
Doxepin Hcl20$1,404
Atorvastatin Calcium108$1,300

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$67$80,16044 claims
Lilly USA, LLCMounjaro$101$20,51214 claims
MerckJanuvia$13$15,10412 claims
AbbVieSynthroid$125$4,21453 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Hamilton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →